Doctor profile · Federal record
Dr. KIMBERLY CAMPBELL, M.D.
Cardiovascular Disease Physician (CMS: CARDIOVASCULAR DISEASE (CARDIOLOGY)) · SPRINGFIELD, PA
- NPI 1700092491
- Accepts Medicare
- MIPS 98.3 / 100 · 2023
- 22 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
760 W SPROUL RD STE 200
SPRINGFIELD, PA 190644005
(484) 386-6300
fax (484) 380-3178 - Mailing address
-
207 N BROAD ST, 3RD FLR.
PHILA, PA 191071500
Credentials & registration
- NPI registered
- May 2007 — 19 yrs on file
- Profile last updated
- February 19, 2025
- Year of graduation
- 2004 — 22 yrs since
- Specialty taxonomy
- 207RC0000X — NUCC code
- State license (1)
- Pennsylvania #MD430882
- Medicaid
- PA #102455890
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1700092491. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
6,106
Distinct HCPCS
10
Medicare allowed
$1,139,476
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
93010 |
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 1,195 | 778 | $8 | |
93000 |
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 830 | 483 | $15 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 785 | 469 | $135 | |
J1245 |
Injection, dipyridamole, per 10 mg | 694 | 82 | $4 | |
J2785 |
Injection, regadenoson, 0.1 mg | 618 | 156 | $13 | |
93015 |
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 242 | 242 | $74 | |
A9555 |
Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 224 | 219 | $788 | |
78431 |
Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | 219 | 219 | $2,595 | |
78434 |
Nuclear medicine study of heart muscle blood flow by pet | 191 | 191 | $197 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 166 | 114 | $83 |
In context: peer comparison
Among 2 peers in this city , average services per provider: 200. This provider delivers 31× the peer median.Open Payments
Industry payments received
All-time total
$649
Transactions
29
Manufacturers
13
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 7 | $145.13 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $107.19 | |
| Kiniksa Pharmaceuticals International, plc | 3 | $69.10 | |
| Amgen Inc. | 3 | $59.52 | |
| E.R. Squibb & Sons, L.L.C. | 2 | $43.85 | |
| Impulse Dynamics (USA) Inc. | 1 | $42.15 | |
| PFIZER INC. | 2 | $37.65 | |
| Esperion Therapeutics, Inc. | 2 | $36.26 | |
| SCPHARMACEUTICALS INC. | 1 | $31.86 | |
| Janssen Pharmaceuticals, Inc | 1 | $28.52 | |
| Merck Sharp & Dohme LLC | 1 | $21.95 | |
| SANOFI-AVENTIS U.S. LLC | 1 | $15.40 | |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $10.28 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
3,367
Patients
943
Total drug cost
$461,044
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Atorvastatin Calcium | Generic | 544 | 159 | $8,400 |
| Metoprolol Succinate | Generic | 539 | 138 | $10,569 |
| Eliquis (Apixaban) | Brand | 330 | 65 | $308,667 |
| Amlodipine Besylate | Generic | 277 | 83 | $2,775 |
| Furosemide | Generic | 262 | 83 | $2,027 |
| Rosuvastatin Calcium | Generic | 229 | 73 | $6,075 |
| Lisinopril | Generic | 183 | 52 | $1,693 |
| Losartan Potassium | Generic | 181 | 51 | $2,898 |
| Metoprolol Tartrate | Generic | 162 | 49 | $1,934 |
| Xarelto (Rivaroxaban) | Brand | 135 | 26 | $106,808 |